Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of Mirum Pharmaceuticals Inc (NASDAQ: MIRM) was $50.80 for the day, up 0.20% from the previous closing price of $50.70. In other words, the price has increased by $0.20 from its previous closing price. On the day, 0.41 million shares were traded. MIRM stock price reached its highest trading level at $51.0675 during the session, while it also had its lowest trading level at $49.91.
Ratios:
Our analysis of MIRM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.04 and its Current Ratio is at 3.22. In the meantime, Its Debt-to-Equity ratio is 1.36 whereas as Long-Term Debt/Eq ratio is at 1.35.
On April 17, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $48.
H.C. Wainwright reiterated its Buy rating for the stock on December 18, 2023, while the target price for the stock was revised from $60 to $58.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 11 ’25 when Fairey William sold 3,203 shares for $48.42 per share. The transaction valued at 155,091 led to the insider holds 2,500 shares of the business.
WILLIAM C FAIREY bought 3,203 shares of MIRM for $155,091 on Jun 11 ’25. On Jun 02 ’25, another insider, Ramasastry Saira, who serves as the Director of the company, sold 5,703 shares for $46.20 each. As a result, the insider received 263,492 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MIRM now has a Market Capitalization of 2516362752 and an Enterprise Value of 2555845120. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.64 while its Price-to-Book (P/B) ratio in mrq is 10.77. Its current Enterprise Value per Revenue stands at 6.739 whereas that against EBITDA is -48.865.
Stock Price History:
The Beta on a monthly basis for MIRM is 0.95, which has changed by 0.6313423 over the last 52 weeks, in comparison to a change of 0.092761636 over the same period for the S&P500. Over the past 52 weeks, MIRM has reached a high of $54.23, while it has fallen to a 52-week low of $28.56. The 50-Day Moving Average of the stock is 15.95%, while the 200-Day Moving Average is calculated to be 16.15%.
Shares Statistics:
MIRM traded an average of 432.91K shares per day over the past three months and 469850 shares per day over the past ten days. A total of 49.45M shares are outstanding, with a floating share count of 40.03M. Insiders hold about 19.18% of the company’s shares, while institutions hold 93.48% stake in the company. Shares short for MIRM as of 1748563200 were 6059537 with a Short Ratio of 14.00, compared to 1745971200 on 6225486. Therefore, it implies a Short% of Shares Outstanding of 6059537 and a Short% of Float of 12.23.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
